Taira, Takuya
Inoue, Akihiko http://orcid.org/0000-0002-9627-3702
Okamoto, Hiroshi
Maekawa, Kunihiko
Hifumi, Toru
Sakamoto, Tetsuya
Kuroda, Yasuhiro
Suga, Masafumi
Nishimura, Takeshi
Ijuin, Shinichi
Ishihara, Satoshi
,
Article History
Received: 9 December 2023
Accepted: 26 March 2024
First Online: 18 April 2024
Declarations
:
: The SAVE-J II study is registered at the University Hospital Medical Information Network Clinical Trials Registry and the Japanese Clinical Trial Registry (registration number: UMIN000036490). This study was approved by the institutional review board (IRB) of Kagawa University on October 25, 2018 (approval number:2018–110), as well as by each participating institution. In addition, the IRB of Hyogo Emergency Medical Center (Kobe, Japan) approved the present secondary analysis on October 19, 2022, according to the IRB ethical standards for human experimentation and the Helsinki Declaration of 1975 (approval number: 2022007).
: The local committee waived the requirement for patient consent owing to the retrospective nature of the study.
: The authors declare no competing interests.